CN1214011C - 作为整联蛋白拮抗剂的间-氮杂环氨基苯甲酸化合物及其衍生物 - Google Patents
作为整联蛋白拮抗剂的间-氮杂环氨基苯甲酸化合物及其衍生物 Download PDFInfo
- Publication number
- CN1214011C CN1214011C CNB998035815A CN99803581A CN1214011C CN 1214011 C CN1214011 C CN 1214011C CN B998035815 A CNB998035815 A CN B998035815A CN 99803581 A CN99803581 A CN 99803581A CN 1214011 C CN1214011 C CN 1214011C
- Authority
- CN
- China
- Prior art keywords
- compound
- solution
- add
- preparation
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/12—Nitrogen atoms not forming part of a nitro radical
- C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3427098A | 1998-03-04 | 1998-03-04 | |
US09/034,270 | 1998-03-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1291978A CN1291978A (zh) | 2001-04-18 |
CN1214011C true CN1214011C (zh) | 2005-08-10 |
Family
ID=21875345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB998035815A Expired - Fee Related CN1214011C (zh) | 1998-03-04 | 1999-02-22 | 作为整联蛋白拮抗剂的间-氮杂环氨基苯甲酸化合物及其衍生物 |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP1060164A1 (ru) |
JP (1) | JP2002505323A (ru) |
KR (1) | KR20010041584A (ru) |
CN (1) | CN1214011C (ru) |
AP (1) | AP1244A (ru) |
AR (1) | AR018139A1 (ru) |
AU (1) | AU753230B2 (ru) |
BG (1) | BG104740A (ru) |
BR (1) | BR9908470A (ru) |
CA (1) | CA2322207A1 (ru) |
EA (1) | EA200000804A1 (ru) |
EE (1) | EE200000506A (ru) |
GE (1) | GEP20033118B (ru) |
HR (1) | HRP20000574A2 (ru) |
HU (1) | HUP0100865A3 (ru) |
ID (1) | ID25591A (ru) |
IL (1) | IL137653A0 (ru) |
IS (1) | IS5582A (ru) |
MY (1) | MY123908A (ru) |
NO (1) | NO315703B1 (ru) |
NZ (1) | NZ506598A (ru) |
OA (1) | OA11530A (ru) |
PL (1) | PL342726A1 (ru) |
SK (1) | SK13002000A3 (ru) |
TR (1) | TR200002542T2 (ru) |
UA (1) | UA71906C2 (ru) |
WO (1) | WO1999044994A1 (ru) |
YU (1) | YU52000A (ru) |
ZA (1) | ZA994406B (ru) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9805655D0 (en) | 1998-03-16 | 1998-05-13 | Celltech Therapeutics Ltd | Chemical compounds |
GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
GB9821061D0 (en) | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
US6518283B1 (en) | 1999-05-28 | 2003-02-11 | Celltech R&D Limited | Squaric acid derivatives |
US6455539B2 (en) | 1999-12-23 | 2002-09-24 | Celltech R&D Limited | Squaric acid derivates |
EP1332132B1 (en) | 2000-04-17 | 2007-10-10 | UCB Pharma, S.A. | Enamine derivatives as cell adhesion molecules |
US6545013B2 (en) | 2000-05-30 | 2003-04-08 | Celltech R&D Limited | 2,7-naphthyridine derivatives |
US6403608B1 (en) | 2000-05-30 | 2002-06-11 | Celltech R&D, Ltd. | 3-Substituted isoquinolin-1-yl derivatives |
US6921767B2 (en) * | 2000-06-15 | 2005-07-26 | Pharmacia Corporation | Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives |
JP2004505110A (ja) | 2000-08-02 | 2004-02-19 | セルテック アール アンド ディ リミテッド | 3位置換イソキノリン−1−イル誘導体 |
MXPA05006732A (es) * | 2002-12-20 | 2005-09-08 | Pharmacia Corp | El isomero r de compuesto de beta-aminoacido como derivados de antagonistas de receptor de la integrina. |
UA87854C2 (en) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
US20070015814A1 (en) * | 2005-06-10 | 2007-01-18 | Ernest Kun | Parp Modulators and Treatment of Cancer |
US8313729B2 (en) | 2007-03-01 | 2012-11-20 | Medibeacon, LLC | Integrated photoactive small molecules and uses thereof |
JP4792124B1 (ja) * | 2010-11-15 | 2011-10-12 | エフイートレード株式会社 | 車両用保護フィルムの型取り方法、及び、車両用保護フィルムの製造方法 |
KR20150038185A (ko) | 2012-07-18 | 2015-04-08 | 세인트 루이스 유니버시티 | 인테그린 길항제로서의 베타 아미노산 유도체 |
US8716226B2 (en) | 2012-07-18 | 2014-05-06 | Saint Louis University | 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists |
RU2016146826A (ru) | 2014-05-30 | 2018-07-04 | Пфайзер Инк. | Производные карбонитрилов как селективные модуляторы андрогенового рецептора |
US9856201B2 (en) * | 2014-06-04 | 2018-01-02 | Monsanto Technology Llc | 3,6-dichlorosalicylic acid compounds and related synthetic processes |
KR20180107121A (ko) | 2015-12-30 | 2018-10-01 | 세인트 루이스 유니버시티 | 팬 인테그린 길항제로서의 메타-아자사이클릭 아미노 벤조산 유도체 |
WO2021230325A1 (ja) | 2020-05-14 | 2021-11-18 | 宇部興産株式会社 | 1,4,5,6-テトラヒドロピリミジン-2-アミン誘導体 |
WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0850221B1 (en) * | 1995-08-30 | 2001-07-18 | G.D. Searle & Co. | Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
-
1999
- 1999-02-11 ZA ZA9904406A patent/ZA994406B/xx unknown
- 1999-02-22 KR KR1020007009774A patent/KR20010041584A/ko not_active Application Discontinuation
- 1999-02-22 TR TR2000/02542T patent/TR200002542T2/xx unknown
- 1999-02-22 SK SK1300-2000A patent/SK13002000A3/sk unknown
- 1999-02-22 AU AU32947/99A patent/AU753230B2/en not_active Ceased
- 1999-02-22 EP EP99937927A patent/EP1060164A1/en active Pending
- 1999-02-22 GE GEAP19995537A patent/GEP20033118B/en unknown
- 1999-02-22 AP APAP/P/2000/001893A patent/AP1244A/en active
- 1999-02-22 IL IL13765399A patent/IL137653A0/xx unknown
- 1999-02-22 YU YU52000A patent/YU52000A/sh unknown
- 1999-02-22 ID IDW20001695A patent/ID25591A/id unknown
- 1999-02-22 EE EEP200000506A patent/EE200000506A/xx unknown
- 1999-02-22 HU HU0100865A patent/HUP0100865A3/hu unknown
- 1999-02-22 BR BR9908470-8A patent/BR9908470A/pt not_active Application Discontinuation
- 1999-02-22 PL PL99342726A patent/PL342726A1/xx unknown
- 1999-02-22 EA EA200000804A patent/EA200000804A1/ru unknown
- 1999-02-22 WO PCT/US1999/003281 patent/WO1999044994A1/en not_active Application Discontinuation
- 1999-02-22 CN CNB998035815A patent/CN1214011C/zh not_active Expired - Fee Related
- 1999-02-22 CA CA002322207A patent/CA2322207A1/en not_active Abandoned
- 1999-02-22 JP JP2000534538A patent/JP2002505323A/ja active Pending
- 1999-02-22 UA UA2000095148A patent/UA71906C2/uk unknown
- 1999-02-22 OA OA1200000238A patent/OA11530A/en unknown
- 1999-02-22 NZ NZ506598A patent/NZ506598A/en unknown
- 1999-03-02 AR ARP990100880A patent/AR018139A1/es unknown
- 1999-03-03 MY MYPI99000772A patent/MY123908A/en unknown
-
2000
- 2000-08-04 IS IS5582A patent/IS5582A/is unknown
- 2000-08-30 NO NO20004316A patent/NO315703B1/no not_active IP Right Cessation
- 2000-09-01 HR HR20000574A patent/HRP20000574A2/hr not_active Application Discontinuation
- 2000-09-01 BG BG104740A patent/BG104740A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO1999044994A1 (en) | 1999-09-10 |
NO20004316D0 (no) | 2000-08-30 |
AP1244A (en) | 2004-02-04 |
AU3294799A (en) | 1999-09-20 |
BG104740A (en) | 2001-02-28 |
YU52000A (sh) | 2003-02-28 |
JP2002505323A (ja) | 2002-02-19 |
MY123908A (en) | 2006-06-30 |
IL137653A0 (en) | 2001-10-31 |
IS5582A (is) | 2000-08-04 |
HUP0100865A3 (en) | 2001-11-28 |
AU753230B2 (en) | 2002-10-10 |
CA2322207A1 (en) | 1999-09-10 |
EA200000804A1 (ru) | 2001-04-23 |
NO315703B1 (no) | 2003-10-13 |
NZ506598A (en) | 2003-07-25 |
BR9908470A (pt) | 2000-12-05 |
SK13002000A3 (sk) | 2001-07-10 |
EP1060164A1 (en) | 2000-12-20 |
AP2000001893A0 (en) | 2000-09-30 |
AR018139A1 (es) | 2001-10-31 |
TR200002542T2 (tr) | 2001-05-21 |
CN1291978A (zh) | 2001-04-18 |
HUP0100865A2 (hu) | 2001-08-28 |
KR20010041584A (ko) | 2001-05-25 |
ZA994406B (en) | 2000-02-11 |
NO20004316L (no) | 2000-11-06 |
EE200000506A (et) | 2002-04-15 |
ID25591A (id) | 2000-10-19 |
OA11530A (en) | 2004-05-17 |
UA71906C2 (en) | 2005-01-17 |
GEP20033118B (en) | 2003-11-25 |
HRP20000574A2 (en) | 2001-08-31 |
PL342726A1 (en) | 2001-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1214011C (zh) | 作为整联蛋白拮抗剂的间-氮杂环氨基苯甲酸化合物及其衍生物 | |
CN1207288C (zh) | 逆病毒蛋白酶抑制化合物 | |
CN1097051C (zh) | N-杂芳基吡啶磺酰胺衍生物及其作为内皮素拮抗剂的用途 | |
CN1043997C (zh) | 2,6-二氨基嘌呤衍生物及其用途和含该衍生物的药物组合物 | |
CN1158256C (zh) | 吡咯烷衍生物-ccr-3受体拮抗剂 | |
CN1083452C (zh) | 抑制蛋白质酪氨酸激酶介导的细胞增殖的吡啶并[2,3-d]嘧啶 | |
CN1045768C (zh) | 一种血管紧张肽ⅱ拮抗剂化合物及其制备方法和用途 | |
CN1078889C (zh) | 非肽类速激肽受体拮抗剂 | |
CN1154494C (zh) | 腺苷a3受体调节剂 | |
CN1218943C (zh) | 4-嘧啶基-n-酰基-l-苯基丙氨酸类化合物 | |
CN1134148A (zh) | 抗血栓形成的脒基苯丙氨酸和脒基吡啶丙氨酸的衍生物 | |
CN1304406A (zh) | 作为玻连蛋白拮抗剂的杂环甘氨酰β-丙氨酸衍生物 | |
CN1431999A (zh) | 具有血管损伤活性的吲哚衍生物 | |
CN1788001A (zh) | 可用于治疗赘生性疾病、炎性和免疫系统病症的2,4-二(苯氨基)嘧啶 | |
CN1518541A (zh) | 苯基衍生物 | |
CN1282316A (zh) | 用作神经氨酸酶抑制剂的取代环戊烷和环戊烯化合物 | |
CN1802159A (zh) | 治疗哮喘及其它炎症或免疫性疾病的具有ccr3拮抗活性的2-苯氧基-和2-苯基磺酰胺衍生物 | |
CN1238760A (zh) | N-(芳基/杂芳基/烷基乙酰基)氨基酸酰胺类,含有这类化合物的药物组合物,及用这类化合物抑制β-淀粉样肽释放和或合成的方法 | |
CN1717396A (zh) | Chk-、Pdk-和Akt-抑制嘧啶,其制备及作为药物的用途 | |
CN1950343A (zh) | 胺系碱性化合物及其用途 | |
CN1910158A (zh) | 含有氮杂环的β淀粉样蛋白生成的杂环磺酰胺抑制剂 | |
CN101031555A (zh) | 具有vap-1抑制活性的噻唑衍生物 | |
CN1131665A (zh) | 哌嗪衍生物、含该类化合物的药物、其用途及制备方法 | |
CN1479715A (zh) | 用于抑制由白介素8诱导的中性粒细胞趋化作用的酰胺 | |
CN1571786A (zh) | 烷基醚衍生物或其盐 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |